Business Context and Reporting Period
This Form 8-K is a Current Report filed by Enochian Biosciences Inc. (not Lunai Bioworks Inc.) on March 13, 2023. The registrant is a Delaware corporation with its principal executive offices in Los Angeles, CA. The filing reports "Other Events" under Item 8.01, specifically the issuance of a press release dated March 13, 2023, which is attached as Exhibit 99.1.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document serves solely to announce the release of a press statement and does not contain audited or unaudited financial tables.
Material Changes
No material financial changes versus prior periods are detailed in this filing. The only reported event is the distribution of a press release regarding the Company's activities.
Guidance, Outlook, and Risks
The filing explicitly states that the information contained in Item 8.01 and the attached press release (Exhibit 99.1) is not deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934. Consequently, the text does not incorporate the press release's content by reference, and no specific guidance, outlook, risks, or contingencies are detailed within the body of this 8-K.
Investor Verification Checklist
- Verify the actual content of the press release (Exhibit 99.1) to understand the specific event being reported, as the 8-K body does not summarize it.
- Confirm the company name is Enochian Biosciences Inc. (Ticker: ENOB), noting the discrepancy with the requested "Lunai Bioworks Inc."
- Review the press release separately for any forward-looking statements, as they are not legally incorporated into this filing.
- Check subsequent filings for any financial impact resulting from the event announced in the press release.